Aster DM Quality Care begins operations with 10,600 beds

Merger goes live and a new listed platform starts

Aster DM Quality Care commenced operations on Thursday after the completion of the merger between Aster DM Healthcare and Blackstone-backed Quality Care India (QCIL), according to a stock exchange filing. The combined platform brings together four hospital brands: Aster DM, CARE Hospitals, Evercare and KIMSHEALTH. The integration expands the group’s footprint in India at a time when the company has been sharpening its focus on the domestic market. The start of operations is the key corporate milestone that follows a long process of board approvals, shareholder voting and regulatory clearances referenced in earlier updates.

Management has presented the combination as a scale-led move, with emphasis on procurement efficiency and operational integration across the combined network. The filing-led update positions the merged entity as a broader, multi-brand hospital platform rather than a single-chain consolidation.

What the combined network looks like now

The merged entity operates more than 10,600 beds across 39 hospitals, spread across 28 cities in nine states. Another company update describes the footprint as “10,625+ beds” across the same 39 hospitals, reflecting slightly different reporting formats used in various communications. Earlier deal announcements also referred to a network of 38 hospitals and 10,150+ beds across 27 cities at the signing stage, indicating that the operating footprint increased between the agreement date and the merger completion.

In addition to scale, the company highlighted a reach beyond metro markets, pointing to tier 2 and tier 3 cities such as Nagpur, Aurangabad, Vijayawada, Guntur, Bhubaneswar, Raipur, Nagercoil, Kolhapur, Kannur, Kasaragod, and Kottakkal. The stated objective is to reduce the need for patients to travel to metropolitan centres for complex healthcare. The combined portfolio is intended to support specialist care, advanced treatment, and medical technology expansion across these markets.

Leadership structure after integration

In the new combined entity, Dr. Azad Moopen continues as Executive Chairman. Varun Khanna will lead the business as Managing Director and Group CEO, as disclosed in the company communication. The leadership continuity is framed as a way to maintain operating momentum while the organisation integrates four hospital brands under a single listed platform.

Aster has also indicated that its board members met Quality Care representatives in March to finalise key decisions on the merger. That meeting is one of the last referenced governance steps before the combined entity commenced operations.

Procurement and operating efficiency: management’s stated rationale

Dr. Azad Moopen highlighted procurement as a core benefit of the merger in an email response cited in the report. He said the combined purchasing power of hospitals strengthens procurement leverage, enabling better vendor negotiations, cost optimisation, streamlined sourcing operations and enhanced inventory efficiency. For hospital operators, procurement scale matters because medical consumables, devices, implants and pharmaceuticals represent a significant portion of operating costs.

The company’s emphasis on sourcing and inventory efficiency suggests that part of the synergy thesis is operational, not only geographic expansion. Procurement leverage typically improves when standardisation increases across a larger base of hospitals, but the integration task also requires aligning systems, clinical protocols, and supplier contracts across multiple brands.

Expansion target: moving from 10,600-plus to 14,710 beds

Management has set a multi-year target to expand capacity to over 14,710 beds in the coming years. One update states the group plans to add over 4,080 beds, with 2,368 beds coming from Aster and the rest from QCIL. Separately, earlier deal commentary referenced an ambition to add about 3,500 new beds between FY2024 and FY2027, and Reuters also noted a plan to add another 3,500 beds by fiscal year 2027 funded through internal earnings.

The company has also outlined project-level additions in different communications. These include two new hospitals in Bengaluru with capacities of 430 and 500 beds, expansion at Aster CMI Hospital and Aster Whitefield, and in Kerala a 454-bed facility under construction in Thiruvananthapuram alongside a 100-bed addition at Aster Medcity in Kochi. Another update mentioned Aster Kasaragod Hospital commencing operations in October 2025 and referred to additional bed additions at Aster CMI and Whitefield.

Capital plan: Rs 2,300 crore investment for growth

A separate report stated the India-listed hospital chain plans to invest around Rs 2,300 crore to add 2,368 beds through a mix of greenfield projects and selective acquisitions over the next few years. The investment plan is tied to Aster’s India expansion focus following the separation of its GCC business two years ago, with India described as its fastest-growing and largest market.

While the merged platform has multiple growth levers, the disclosed capex plan provides a measurable near-term indicator of capacity creation. Execution will depend on timelines for construction, equipment commissioning, and staffing, which are typically the longest lead items in hospital expansion.

Approvals and deal history: from signing to shareholder vote

The definitive merger agreement between Aster and QCIL was signed on November 29, 2024, according to a company statement. At that stage, the merged listed entity was to be named Aster DM Quality Care Limited, combining Aster DM, CARE Hospitals, KIMSHEALTH and Evercare. The transaction was described as subject to shareholder and regulatory approvals, with an expectation in one communication that the merger would close by Q3 FY26.

On the approvals front, Aster DM Healthcare secured shareholder and unsecured trade creditor endorsement, with 96.68% of shareholders voting in favour of the merger. A separate note also referenced the March 12, 2026 vote date for shareholder approval. These steps set the foundation for the merger completion and the commencement of operations under the combined platform.

Shareholding and control points referenced in reports

One deal description stated that based on the agreed share swap ratio, Aster shareholders would hold 57.3% and Quality Care shareholders 42.7% in the merged entity. Reuters also reported that control of the merged organisation would be shared between Aster’s primary shareholders and Blackstone, holding 24% and 30.7%, respectively, while reiterating the 57.3% and 42.7% split between Aster and Quality Care shareholders.

These figures were presented in the context of the merger announcement and reflect how ownership and influence are distributed across key stakeholders. The operating reality after merger completion will be shaped by governance arrangements, board composition, and how integration priorities are sequenced across the four brands.

Key metrics snapshot

Timeline highlights mentioned across updates

Why this matters for India’s hospital sector

The merger brings together a large multi-brand network with a stated ambition to be among India’s top three hospital chains by revenue and bed capacity, as referenced in multiple reports. Scale has become more important for hospital operators due to rising input costs, the need for advanced technology, and expanding specialist care into non-metro markets. A network spanning 39 hospitals creates opportunities for shared procurement, standardised clinical pathways, and more efficient use of high-end equipment across sites.

At the same time, integration complexity is higher when four brands are involved and when the network spans many cities and states. The company’s focus on procurement leverage and inventory efficiency indicates that integration benefits are expected not only from expansion, but also from operational execution across the combined footprint.

Conclusion

Aster DM Quality Care has begun operations after completing the merger between Aster DM Healthcare and QCIL, combining four hospital brands into a 39-hospital, 10,600-plus bed platform. Management has outlined procurement efficiencies and a multi-year capacity target of over 14,710 beds, supported by disclosed expansion projects and a reported Rs 2,300 crore investment plan. The next phase will be defined by the pace of bed additions, commissioning of new facilities, and the execution of integration priorities across the combined network.